Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2020-04-23 Board/Management Inform…
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Adherium appoints Mike Motion CEO/Director and Anne Bell CFO 3 pages 187.1KB
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of new senior executives (CEO and CFO) at Adherium, including details about their backgrounds, roles, and contractual terms. It does not contain financial statements, earnings data, or detailed financial analysis. The focus is on management changes and executive appointments. Therefore, it fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a report publication notice, but a full announcement of management changes.
2020-04-23 English
Adherium and Planet Innovation partner in tech development 2 pages 134.1KB
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a strategic partnership between Adherium and Planet Innovation to develop inhaled medication adherence devices and enhanced digital software platforms. It discusses the company's commercial strategy, product development, and market opportunities, particularly in the context of remote patient monitoring and telehealth. There are no financial statements, regulatory filings, voting results, or management changes detailed. The content is primarily an update on business development and partnership, which fits best under Capital/Financing Update (CAP) as it relates to strategic business growth and investment in product development. The document length is 5369 characters, which is sufficient for a detailed announcement but does not contain financial data or report content to classify as an Annual Report or Interim Report. Therefore, the most appropriate classification is CAP with high confidence.
2020-04-20 English
Initial Director's Interest Notice - J Ward-Lilley 2 pages 126.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options and contracts related to the director. This is a report of personal share transactions or interests by a company director. The document length is short (2361 characters) and contains specific information about director's securities holdings and contracts, which matches the definition of Director's Dealing filings. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is Director's Dealing (DIRS).
2020-04-19 English
Adherium announces collaboration with HGE Health in COPD 3 pages 142.8KB
Capital/Financing Update Classification · 85% confidence The document is a press release announcing a new collaboration between Adherium Limited and HGE Health for disease management in COPD. It discusses the strategic partnership, technology integration, and future commercial plans. There are no financial statements, regulatory filings, voting results, or management changes. The content is focused on a business update and partnership announcement rather than a formal financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Capital/Financing Update (CAP) as it relates to a strategic commercial collaboration that could impact the company's business and capital strategy.
2020-04-15 English
Proposed issue of Securities - ADR 5 pages 27.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Adherium Limited regarding a proposed issue of securities, specifically a placement of options. It details the number of securities to be issued, the purpose, issue price, and compliance with ASX listing rules. The content is focused on informing the market about a capital raising event rather than providing a financial report or detailed analysis. The document length is about 5677 characters, which is consistent with a detailed announcement but not a full financial report. There is no financial statement or management discussion present. Therefore, this fits the category of a Capital/Financing Update (CAP).
2020-04-13 English
Appendix 3G 13 pages 247.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3G Notification of issue, conversion or payment up of equity +securities' and is addressed to the ASX (Australian Securities Exchange). It details the issuance of unquoted options under an employee incentive scheme, including specifics such as the number of securities, security description, and recipients who are key management personnel. The document is a formal notification of a securities issuance event, specifically related to employee incentive schemes, and includes detailed information about the securities issued. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is not an annual report, earnings release, or any other type of report but a regulatory announcement about a capital issuance event.
2020-04-13 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.